Skip to main content
VCbacked
Log inGet Started

Diakonos Oncology

Houston, United States

Diakonos Oncology biotech firm developing dendritic cell vaccines targeting difficult cancer types.

$7.0M raised
Dec 2025
Grant
BiotechnologyOncologyPharmaceutical

Top Investors

Baylor College of MedicineCancer Prevention and Research Institute of TexasRestem GroupBrain Tumor Investment FundButtonwood Titan QC Fund

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Diakonos Oncology

How much funding has Diakonos Oncology raised?
Diakonos Oncology has raised $7.0M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Who are Diakonos Oncology's investors?
Diakonos Oncology's investors include Baylor College of Medicine, Cancer Prevention and Research Institute of Texas, Restem Group, Brain Tumor Investment Fund, Buttonwood Titan QC Fund.
Where is Diakonos Oncology headquartered?
Diakonos Oncology is headquartered in Houston, United States.
What does Diakonos Oncology do?
Diakonos Oncology biotech firm developing dendritic cell vaccines targeting difficult cancer types.
What stage is Diakonos Oncology at?
Diakonos Oncology is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Diakonos Oncology — Funding & Investors." VCBacked, December 10, 2025, https://www.vcbacked.co/company/diakonos-oncology. Accessed July 2, 2026.
APA
VCBacked. (2025). Diakonos Oncology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/diakonos-oncology
Wikipedia (cite web)
{{cite web |title=Diakonos Oncology — Funding & Investors |url=https://www.vcbacked.co/company/diakonos-oncology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K